“…52 One such non-nucleotide class of inhibitors is a variety of sulfonates reported active against the ectonucleotidases with K i values in low micro-molar ranges. [57][58][59][60][61] Sulfonates have been reported to be anticancer agents with additional therapeutic potentials. Since 1959, persistent myeloid leukaemia, refractory lymphoma and myeloproliferative ailments have all been treated with busulfan, one of the alkyl sulfonate.…”